{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:58Z","timestamp":1786998358348,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00065"],"award-info":[{"award-number":["75N93019C00065"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHS75N93019C00076"],"award-info":[{"award-number":["HHS75N93019C00076"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.xcrm.2023.101088","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T04:18:58Z","timestamp":1685333938000},"page":"101088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Targets and cross-reactivity of human T\u00a0cell recognition of common cold coronaviruses"],"prefix":"10.1016","volume":"4","author":[{"given":"Alison","family":"Tarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Methot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara M.","family":"Narowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mallal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Filaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Weiskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmanane","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Scheuermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2209-5966","authenticated-orcid":false,"given":"Alba","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101088_bib1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.immuni.2022.04.010","article-title":"Inducing broad-based immunity against viruses with pandemic potential","volume":"55","author":"Sette","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101088_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101088_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.xcrm.2023.101088_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2023.101088_bib5","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3201\/eid2810.220396","article-title":"Seasonality of common human coronaviruses, United States, 2014-2021(1)","volume":"28","author":"Shah","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101088_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.immuni.2020.07.005","article-title":"Lessons for COVID-19 immunity from other coronavirus infections","volume":"53","author":"Sariol","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101088_bib7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101088_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/cid\/ciac310","article-title":"Observations and perspectives on adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"75","author":"Dan","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101088_bib9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101088_bib10","doi-asserted-by":"crossref","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T\u00a0cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101088_bib11","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.3390\/ijms23137155","article-title":"Early and polyantigenic CD4 T\u00a0cell responses correlate with mild disease in acute COVID-19 donors","volume":"23","author":"Tarke","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2023.101088_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2787-6","article-title":"Animal models for COVID-19","volume":"586","author":"Mu\u00f1oz-Fontela","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101088_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/pai.13263","article-title":"Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover","volume":"31","author":"Soresina","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib14","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","volume":"27","author":"Apostolidis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib15","doi-asserted-by":"crossref","first-page":"e156978","DOI":"10.1172\/jci.insight.156978","article-title":"Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T\u00a0cell immunity and function","volume":"7","author":"Sabatino","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2023.101088_bib16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T\u00a0cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101088_bib17","doi-asserted-by":"crossref","first-page":"100355","DOI":"10.1016\/j.xcrm.2021.100355","article-title":"Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T\u00a0cell reactivity in infected or vaccinated individuals","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib18","doi-asserted-by":"crossref","first-page":"eabj1750","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T\u00a0cell responses in COVID-19 convalescent donors and vaccine recipients","volume":"6","author":"Geers","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib19","doi-asserted-by":"crossref","first-page":"eabo2202","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib20","doi-asserted-by":"crossref","first-page":"747830","DOI":"10.3389\/fimmu.2021.747830","article-title":"Recognition of variants of concern by antibodies and T\u00a0cells induced by a SARS-CoV-2 inactivated vaccine","volume":"12","author":"Melo-Gonz\u00e1lez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib21","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.chom.2021.10.003","article-title":"Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner","volume":"29","author":"Keeton","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101088_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T\u00a0cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T\u00a0cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib24","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1038\/s41467-021-27064-3","article-title":"Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T\u00a0cell and IgG response following seasonal influenza vaccination","volume":"12","author":"Wild","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101088_bib25","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1164\/rccm.201411-1988OC","article-title":"Natural T\u00a0cell-mediated protection against seasonal and pandemic influenza. Results of the flu watch cohort study","volume":"191","author":"Hayward","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib26","doi-asserted-by":"crossref","first-page":"12241","DOI":"10.1128\/JVI.01563-08","article-title":"Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans","volume":"82","author":"Assarsson","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101088_bib27","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-020-0389-z","article-title":"Pre-existing immunity to SARS-CoV-2: the knowns and unknowns","volume":"20","author":"Sette","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib29","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.immuni.2020.11.016","article-title":"Low-avidity CD4(+) T\u00a0cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19","volume":"53","author":"Bacher","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101088_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41577-020-00460-4","article-title":"Cross-reactive memory T\u00a0cells and herd immunity to SARS-CoV-2","volume":"20","author":"Lipsitch","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib31","doi-asserted-by":"crossref","first-page":"e143380","DOI":"10.1172\/JCI143380","article-title":"Recent endemic coronavirus infection is associated with less-severe COVID-19","volume":"131","author":"Sagar","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101088_bib32","doi-asserted-by":"crossref","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T\u00a0cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101088_bib33","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101088_bib34","doi-asserted-by":"crossref","first-page":"eabd2071","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T\u00a0cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T\u00a0cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101088_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.abd3871","article-title":"Selective and cross-reactive SARS-CoV-2 T\u00a0cell epitopes in unexposed humans","volume":"370","author":"Mateus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101088_bib37","doi-asserted-by":"crossref","first-page":"eabh1823","DOI":"10.1126\/science.abh1823","article-title":"Cross-reactive CD4+ T\u00a0cells enhance SARS-CoV-2 immune responses upon infection and vaccination","volume":"374","author":"Loyal","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101088_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T\u00a0cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T\u00a0cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101088_bib40","doi-asserted-by":"crossref","first-page":"24384","DOI":"10.1073\/pnas.2015486117","article-title":"Suboptimal SARS-CoV-2-specific CD8(+) T\u00a0cell response associated with the prominent HLA-A\u221702:01 phenotype","volume":"117","author":"Habel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101088_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jpids\/piaa075","article-title":"Severe acute respiratory syndrome coronavirus 2 infections in children: multicenter surveillance, United States, january-march 2020","volume":"9","author":"Rha","year":"2020","journal-title":"J.\u00a0Pediatric Infect. Dis. Soc."},{"key":"10.1016\/j.xcrm.2023.101088_bib42","article-title":"Profound CD8 T\u00a0cell responses towards the SARS-CoV-2 ORF1ab in COVID-19 patients","author":"Gangaev","year":"2021","journal-title":"Res. Sq."},{"key":"10.1016\/j.xcrm.2023.101088_bib43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101088_bib44","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.2001438","article-title":"Genome-wide B cell, CD4(+), and CD8(+) T\u00a0cell epitopes that are highly conserved between human and animal coronaviruses, identified from SARS-CoV-2 as targets for preemptive pan-coronavirus vaccines","volume":"206","author":"Prakash","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib45","doi-asserted-by":"crossref","first-page":"e20202617","DOI":"10.1084\/jem.20202617","article-title":"Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection","volume":"218","author":"Le Bert","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib46","doi-asserted-by":"crossref","first-page":"e0260360","DOI":"10.1371\/journal.pone.0260360","article-title":"SARS-CoV-2 spike protein displays sequence similarities with paramyxovirus surface proteins; a bioinformatics study","volume":"16","author":"Ahmadi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101088_bib47","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.immuni.2022.10.019","article-title":"Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes","volume":"55","author":"Fan","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101088_bib48","doi-asserted-by":"crossref","first-page":"eabq0839","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101088_bib49","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 human T\u00a0cell epitopes: adaptive immune response against COVID-19","volume":"29","author":"Grifoni","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101088_bib50","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.chom.2022.07.012","article-title":"Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic","volume":"30","author":"Yu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101088_bib51","doi-asserted-by":"crossref","first-page":"100204","DOI":"10.1016\/j.xcrm.2021.100204","article-title":"Comprehensive analysis of T\u00a0cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib52","doi-asserted-by":"crossref","first-page":"8202067","DOI":"10.1155\/2020\/8202067","article-title":"Development and validation of a bordetella pertussis whole-genome screening strategy","volume":"2020","author":"da Silva Antunes","year":"2020","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.xcrm.2023.101088_bib53","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","article-title":"CD8(+) T\u00a0cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses","volume":"54","author":"Lineburg","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101088_bib54","doi-asserted-by":"crossref","first-page":"800070","DOI":"10.3389\/fimmu.2022.800070","article-title":"Long-term, CD4(+) memory T\u00a0cell response to SARS-CoV-2","volume":"13","author":"Wirsching","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib55","doi-asserted-by":"crossref","first-page":"e146922","DOI":"10.1172\/JCI146922","article-title":"Functional characterization of CD4+ T\u00a0cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses","volume":"131","author":"Dykema","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101088_bib56","doi-asserted-by":"crossref","first-page":"e1010203","DOI":"10.1371\/journal.ppat.1010203","article-title":"Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T\u00a0cells in prepandemic and COVID-19 convalescent individuals","volume":"17","author":"Johansson","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2023.101088_bib57","doi-asserted-by":"crossref","first-page":"eabn3127","DOI":"10.1126\/sciimmunol.abn3127","article-title":"SARS-CoV-2-specific T\u00a0cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens","volume":"7","author":"Bartolo","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T\u00a0cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101088_bib59","doi-asserted-by":"crossref","first-page":"101505","DOI":"10.1016\/j.smim.2021.101505","article-title":"T cell immunity to SARS-CoV-2","volume":"55","author":"Niessl","year":"2021","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","article-title":"Pre-existing polymerase-specific T\u00a0cells expand in abortive seronegative SARS-CoV-2","volume":"601","author":"Swadling","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101088_bib61","doi-asserted-by":"crossref","first-page":"e2497","DOI":"10.1371\/journal.pntd.0002497","article-title":"Identification of conserved and HLA promiscuous DENV3 T-cell epitopes","volume":"7","author":"Nascimento","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2023.101088_bib62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vaccine.2021.11.076","article-title":"A promiscuous T\u00a0cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T\u00a0cell responses in nonhuman primates","volume":"40","author":"Ribeiro","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2023.101088_bib63","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4049\/jimmunol.165.2.1123","article-title":"HLA-DR-promiscuous T\u00a0cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles","volume":"165","author":"Doolan","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib64","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/JVI.75.9.4195-4207.2001","article-title":"Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes","volume":"75","author":"Wilson","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101088_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0198-8859(96)00138-3","article-title":"Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens","volume":"51","author":"Schipper","year":"1996","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101088_bib67","doi-asserted-by":"crossref","first-page":"101418","DOI":"10.1016\/j.smim.2020.101418","article-title":"Epitope prediction and identification- adaptive T\u00a0cell responses in humans","volume":"50","author":"Sidney","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib68","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101088_bib69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03681-2","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans","volume":"596","author":"Alter","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101088_bib70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/infdis\/jiab176","article-title":"Differential T-cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers","volume":"224","author":"da Silva Antunes","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2023.101088_bib71","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"Edridge","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101088_bib72","doi-asserted-by":"crossref","first-page":"001322-21","DOI":"10.1128\/JVI.00132-21","article-title":"Pre-existing T\u00a0cell memory against Zika virus","volume":"95","author":"Schouest","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101088_bib73","doi-asserted-by":"crossref","first-page":"016411-20","DOI":"10.1128\/JVI.01641-20","article-title":"Identification and characterization of CD4(+) T\u00a0cell epitopes after shingrix vaccination","volume":"94","author":"Voic","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101088_bib74","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.humimm.2010.02.014","article-title":"Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus","volume":"71","author":"Alexander","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib75","doi-asserted-by":"crossref","first-page":"000899-20","DOI":"10.1128\/JVI.00089-20","article-title":"T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species","volume":"94","author":"Grifoni","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2023.101088_bib76","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/s41467-018-05458-0","article-title":"Cross-reactive Dengue virus-specific CD8(+) T\u00a0cells protect against Zika virus during pregnancy","volume":"9","author":"Regla-Nava","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101088_bib77","doi-asserted-by":"crossref","first-page":"107566","DOI":"10.1016\/j.celrep.2020.107566","article-title":"CD4(+) T\u00a0cells cross-reactive with Dengue and Zika viruses protect against Zika virus infection","volume":"31","author":"Wen","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.101088_bib78","doi-asserted-by":"crossref","first-page":"eabf3698","DOI":"10.1126\/sciimmunol.abf3698","article-title":"Discordant neutralizing antibody and T\u00a0cell responses in asymptomatic and mild SARS-CoV-2 infection","volume":"5","author":"Reynolds","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib79","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chom.2022.02.003","article-title":"Development of a T\u00a0cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status","volume":"30","author":"Yu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101088_bib80","doi-asserted-by":"crossref","first-page":"eabc8413","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101088_bib81","article-title":"Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period","author":"Yu","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2023.101088_bib82","doi-asserted-by":"crossref","first-page":"D678","DOI":"10.1093\/nar\/gkac1003","article-title":"Introducing the bacterial and viral bioinformatics resource center (BV-BRC): a resource combining PATRIC, IRD and ViPR","volume":"51","author":"Olson","year":"2023","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:53:59Z","timestamp":1762988039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2666379123002070"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101088","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.01.04.522794","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targets and cross-reactivity of human T\u00a0cell recognition of common cold coronaviruses","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101088"}}